UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical pharmacokinetics of lamivudine

Clinical pharmacokinetics, 1999, Vol.36 (1), p.41-66

1999

Volltextzugriff (PDF)

A Preliminary Evaluation of Nelfinavir Mesylate, an Inhibitor of Human Immunodeficiency Virus (HIV)-1 Protease, to Treat HIV Infection

The Journal of infectious diseases, 1998-06, Vol.177 (6), p.1533-1540

1998

Volltextzugriff (PDF)

Pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with renal dysfunction

Antimicrobial Agents and Chemotherapy, 1996-06, Vol.40 (6), p.1514-1519

1996

Volltextzugriff (PDF)

Pharmacokinetics of lamivudine administered alone and with trimethoprim-sulfamethoxazole

Clinical pharmacology and therapeutics, 1996-05, Vol.59 (5), p.550-558

1996

Volltextzugriff (PDF)

Short-Term Measures of Relative Efficacy Predict Longer-Term Reductions in Human Immunodeficiency Virus Type 1 RNA Levels following Nelfinavir Monotherapy

Antimicrobial Agents and Chemotherapy, 2001-05, Vol.45 (5), p.1438-1443

2001

Volltextzugriff (PDF)

Population Pharmacokinetics of Lamivudine in Adult Human Immunodeficiency Virus-Infected Patients Enrolled in Two Phase III Clinical Trials

Antimicrobial Agents and Chemotherapy, 1999-12, Vol.43 (12), p.3025-3029

1999

Volltextzugriff (PDF)

Equivalent Steady-State Pharmacokinetics of Lamivudine in Plasma and Lamivudine Triphosphate within Cells following Administration of Lamivudine at 300 Milligrams Once Daily and 150 Milligrams Twice Daily

Antimicrobial Agents and Chemotherapy, 2004-01, Vol.48 (1), p.176-182

2004

Volltextzugriff (PDF)

A phase I/II study of 2'-deoxy-3'-thiacytidine (lamivudine) in patients with advanced human immunodeficiency virus infection

The Journal of infectious diseases, 1995-06, Vol.171 (6), p.1438-1447

1995

Volltextzugriff (PDF)

Serum and Cerebrospinal Fluid Pharmacokinetics of Intravenous and Oral Lamivudine in Human Immunodeficiency Virus-Infected Children

Antimicrobial Agents and Chemotherapy, 1998-12, Vol.42 (12), p.3187-3192

1998

Volltextzugriff (PDF)

Abacavir/Lamivudine/Zidovudine As a Combined Formulation Tablet: Bioequivalence Compared with Each Component Administered Concurrently and the Effect of Food on Absorption

Journal of clinical pharmacology, 2001-03, Vol.41 (3), p.277-288

2001

Volltextzugriff (PDF)

Pharmacokinetics, Absolute Bioavailability, and Absorption Characteristics of Lamivudine

Journal of clinical pharmacology, 1995-12, Vol.35 (12), p.1174-1180

1995

Volltextzugriff (PDF)

Altered Pharmacokinetics in the Elderly

Clinics in geriatric medicine, 1990-05, Vol.6 (2), p.257-267

Yuen, Geoffrey J.

1990

Volltextzugriff (PDF)

Population differences in ganciclovir clearance as determined by nonlinear mixed-effects modelling

Antimicrobial Agents and Chemotherapy, 1995-10, Vol.39 (10), p.2350-2352

1995

Volltextzugriff (PDF)

Impact of bioavailability on determination of the maximal tolerated dose of 2',3'-dideoxyinosine in phase I trials

Antimicrobial Agents and Chemotherapy, 1992-06, Vol.36 (6), p.1280-1283

1992

Volltextzugriff (PDF)

A Review of the Pharmacokinetics of Abacavir

Clinical pharmacokinetics, 2008-01, Vol.47 (6), p.351-371

2008

Volltextzugriff (PDF)

A Comparison of the Steady-State Pharmacokinetics and Safety of Abacavir, Lamivudine, and Zidovudine Taken as a Triple Combination Tablet and as Abacavir plus a Lamivudine-Zidovudine Double Combination Tablet by HIV-1-Infected Adults

Pharmacotherapy, 2001-04, Vol.21 (4), p.424-430

2001

Volltextzugriff (PDF)

Once-Daily Quadruple-Drug Therapy with Adefovir Dipivoxil, Lamivudine, Didanosine, and Efavirenz in Treatment-Naive Human Immunodeficiency Virus Type 1–Infected Patients

The Journal of infectious diseases, 2002-10, Vol.186 (7), p.1028-1033

2002

Volltextzugriff (PDF)

Differential extracellular and intracellular concentrations of zidovudine and lamivudine in semen and plasma of HIV-1-infected men

Journal of acquired immune deficiency syndromes (1999), 2008-06, Vol.48 (2), p.156-162

2008

Volltextzugriff (PDF)

Prospective use of optimal sampling theory: Steady-state ciprofloxacin pharmacokinetics in critically ill trauma patients

Clinical pharmacology and therapeutics, 1989-10, Vol.46 (4), p.451-457

1989

Volltextzugriff (PDF)

Abacavir and metabolite pharmacokinetics in HIV-1-infected children and adolescents

Journal of acquired immune deficiency syndromes (1999), 2009-05, Vol.51 (1), p.54-59

2009

Volltextzugriff (PDF)

Use of Nonlinear, Mixed-Effects Modeling for Population Analysis of Ofloxacin: Effects of Age on Oral Drug Pharmacokinetics

Pharmacotherapy, 1992-01, Vol.12 (2), p.88-92

1992

Volltextzugriff (PDF)

Ciprofloxacin pharmacokinetics in critically ill trauma patients

The American journal of medicine, 1989-11, Vol.87 (5A), p.70S-75S

1989

Volltextzugriff (PDF)

Phenytoin dosage predictions in paediatric patients

Clinical pharmacokinetics, 1989-04, Vol.16 (4), p.254-260

1989

Volltextzugriff (PDF)

Pharmacokinetic Interaction between Fosamprenavir-Ritonavir and Rifabutin in Healthy Subjects

Antimicrobial Agents and Chemotherapy, 2008-02, Vol.52 (2), p.534-538

2008

Volltextzugriff (PDF)

Relationship between dideoxyinosine exposure, CD4 counts, and p24 antigen levels in human immunodeficiency virus infection. A phase I trial

Annals of internal medicine, 1992-04, Vol.116 (7), p.562-566

1992

Volltextzugriff (PDF)

1 – 25 von 1.470

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.306)
Mit Volltextzugriff
(1.232)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.075)
Life Sciences & Biomedicine
(705)
Humans
(531)
Biological And Medical Sciences
(383)
Male
(344)
Female
(325)
Medical Sciences
(284)
Physical Sciences
(244)
Adult
(201)
Animals
(198)
Technology
(178)
Middle Aged
(174)
Aged
(139)
Physics
(132)
Fundamental And Applied Biological Sciences. Psychology
(126)
Engineering
(116)
Adolescent
(92)
Pharmacology. Drug Treatments
(87)
Rats
(87)
Biochemistry & Molecular Biology
(84)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(693)
Ingenta
(645)
EZB Electronic Journals Library
(602)
Journals@Ovid Full Text
(477)
Access via ScienceDirect (Elsevier)
(343)
NUS Single-Journal Subscriptions
(315)
IngentaConnect Journals
(262)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(259)
Wiley Online Library Journals
(195)
Wiley Online Library
(135)
IEEE
(99)
Oxford journals
(81)
Springer journals
(77)
Nature Journals Online
(71)
Nexis Uni
(58)
Oxford Journals 2020 Medicine
(49)
JSTOR All Journals
(46)
Ebook Central Perpetual and DDA
(41)
eBooks on EBSCOhost
(39)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(38)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Clinical pharmacokinetics of lamivudine

A Preliminary Evaluation of Nelfinavir Mesylate, an Inhibitor of Human Immunodeficiency Virus (HIV)-1 Protease, to Treat HIV Infection

Pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with renal dysfunction

Pharmacokinetics of lamivudine administered alone and with trimethoprim-sulfamethoxazole

Short-Term Measures of Relative Efficacy Predict Longer-Term Reductions in Human Immunodeficiency Virus Type 1 RNA Levels following Nelfinavir Monotherapy

Population Pharmacokinetics of Lamivudine in Adult Human Immunodeficiency Virus-Infected Patients Enrolled in Two Phase III Clinical Trials

Equivalent Steady-State Pharmacokinetics of Lamivudine in Plasma and Lamivudine Triphosphate within Cells following Administration of Lamivudine at 300 Milligrams Once Daily and 150 Milligrams Twice Daily

A phase I/II study of 2'-deoxy-3'-thiacytidine (lamivudine) in patients with advanced human immunodeficiency virus infection

Serum and Cerebrospinal Fluid Pharmacokinetics of Intravenous and Oral Lamivudine in Human Immunodeficiency Virus-Infected Children

Abacavir/Lamivudine/Zidovudine As a Combined Formulation Tablet: Bioequivalence Compared with Each Component Administered Concurrently and the Effect of Food on Absorption

Pharmacokinetics, Absolute Bioavailability, and Absorption Characteristics of Lamivudine

Altered Pharmacokinetics in the Elderly

Population differences in ganciclovir clearance as determined by nonlinear mixed-effects modelling

Impact of bioavailability on determination of the maximal tolerated dose of 2',3'-dideoxyinosine in phase I trials

A Review of the Pharmacokinetics of Abacavir

A Comparison of the Steady-State Pharmacokinetics and Safety of Abacavir, Lamivudine, and Zidovudine Taken as a Triple Combination Tablet and as Abacavir plus a Lamivudine-Zidovudine Double Combination Tablet by HIV-1-Infected Adults

Once-Daily Quadruple-Drug Therapy with Adefovir Dipivoxil, Lamivudine, Didanosine, and Efavirenz in Treatment-Naive Human Immunodeficiency Virus Type 1–Infected Patients

Differential extracellular and intracellular concentrations of zidovudine and lamivudine in semen and plasma of HIV-1-infected men

Prospective use of optimal sampling theory: Steady-state ciprofloxacin pharmacokinetics in critically ill trauma patients

Abacavir and metabolite pharmacokinetics in HIV-1-infected children and adolescents

Use of Nonlinear, Mixed-Effects Modeling for Population Analysis of Ofloxacin: Effects of Age on Oral Drug Pharmacokinetics

Ciprofloxacin pharmacokinetics in critically ill trauma patients

Phenytoin dosage predictions in paediatric patients

Pharmacokinetic Interaction between Fosamprenavir-Ritonavir and Rifabutin in Healthy Subjects

Relationship between dideoxyinosine exposure, CD4 counts, and p24 antigen levels in human immunodeficiency virus infection. A phase I trial

Suchergebnisse filtern